McCain/Schumer Generic Bill Would End 30-Month Stay Of Approval
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.